Malle, Belgium

Luc Donne Marie-Louise Janssens

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Luc Donne Marie-Louise Janssens

Introduction

Luc Donne Marie-Louise Janssens is a notable inventor based in Malle, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV protease inhibitors. With a total of three patents to his name, Janssens has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Janssens' latest patents include the disclosure of new pseudopolymorphic forms of a HIV protease inhibitor. These forms are specifically related to (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate. The processes for producing these compounds are also detailed in his patents, showcasing his expertise in pharmaceutical chemistry.

Career Highlights

Throughout his career, Janssens has worked with prominent companies in the pharmaceutical industry, including Janssen R&D Ireland and Janssen Sciences Ireland UC. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Hans Wim Pieter Vermeersch and Daniel Joseph Christiaan Thone. Their collaborative efforts have further enhanced the impact of Janssens' work in the pharmaceutical sector.

Conclusion

Luc Donne Marie-Louise Janssens is a distinguished inventor whose work in HIV protease inhibitors has made a significant impact on medical research. His patents and collaborations reflect his dedication to innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…